Vijay Agarwal

Chief Executive Officer at Alpheus Medical.

Raised on Alpheus Medical filings

$60.5M

of $67M offered across 1 Form D filing

Company

Biotech · Chanhassen, MN

Ultrasound-activated drug therapy for glioblastoma

Ultrasound-activated drug therapy for glioblastoma

Alpheus Medical Form D filings
Filed	Security	Sold of offered	Filing
Jul 30, 2026	Equity	$60.5M/ $67M	Form D/A

Also named on Alpheus Medical filings